Wound care
Biofilm is a dense community of microbes that form on the wound surface and delay the wound recovery, are resistant to conventional treatments, making them difficult to eradicate. Wound infections can have a significant impact on the quality of life of patients and their families, leading to prolonged hospitalization, increased healthcare costs, and a higher risk of amputation and mortality.
Over 90% of chronic wounds, such as diabetic foot ulcers, involve biofilm.
Every 30 seconds, a leg is amputated due to a diabetic foot ulcer, with a 50% mortality rate.
After screening over 18,000 formulations, we have developed a unique antimicrobial formulation for wounds, effectively addressing and controlling the various challenges associated with wound infections.
This formulation is not only non-toxic but also possesses antioxidant properties that help accelerate wound recovery.
Benefits include anti-biofilm effects (both prevention and eradication), reduced toxicity, increased antimicrobial potency, decreased chance of future resistance, and effective eradication of chronic wound infections.
Respiratory infection
According to the WHO, respiratory infections are consistently among the top 10 causes of death globally each year. Vulnerable populations such as infants, the elderly, individuals with weakened immune systems, and those with underlying health conditions are at increased risk of experiencing severe complications from respiratory infections.
We are investigating the potential therapeutic benefits of Combiotic, which possesses a range of properties including antibacterial, antibiofilm, antioxidant, and anti-inflammatory effects, in the context of respiratory infections.
Bovine Mastitis
Bovine mastitis, the most prevalent infection in dairy cattle farms, incurs an annual cost exceeding 20 billion dollars worldwide. The overuse of antibiotics for mastitis treatment has contributed to the alarming rise in antimicrobial resistance, resulting in 1.3-5 million related deaths in 2019, and it is a growing problem. The infection and inflammation associated with mastitis brings discomfort, pain, and a decline in milk production for affected animals.
MHCombiotic has developed a patented non- conventional antibiotic technology with applications in both human and animal health. Combiotics, the core of this innovative solution, effectively target and eliminate mastitis-causing microorganisms, even antibiotic-resistant strains.
